Intraoral dosing method of administering (+)-.alpha.-4-(dimethyl

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31135

Patent

active

053547802

ABSTRACT:
A method of therapeutically administering certain BZ.sub.1 specific trifluorobenzodiazepines in order to maximize the BZ.sub.1 effects and minimize the BZ.sub.2 effects on the human central nervous system in order to maximize the anti-anxiety, anticonvulsant and hypnotic effects and minimize the ataxic and incoordination effects of the drug. Also, a method of sublingual administration of trifluorobenzodiazepines and certain other compounds in order to decrease unwanted dealkylated metabolites.

REFERENCES:
patent: 2728779 (1955-12-01), Pohland et al.
patent: 3972995 (1976-08-01), Tsuk et al.
patent: 5198436 (1993-03-01), Ellinwood, Jr. et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Intraoral dosing method of administering (+)-.alpha.-4-(dimethyl does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intraoral dosing method of administering (+)-.alpha.-4-(dimethyl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraoral dosing method of administering (+)-.alpha.-4-(dimethyl will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1658905

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.